SemperVirens Venture Capital, a venture fund investing in companies driving workforce transformation through innovation in the enterprise, healthcare, and financial services sectors, announced that it has closed $177 million across two new funds. The firm had raised $141 million for its Core Fund III for early-stage companies and $36 million for its Growth Opportunity Fund II, which is focused on growth-stage investments in its top-performing companies. The new investment vehicles build on the success of SemperVirens’ Core Fund I and Core Fund II, which currently rank in the top decile and top quartile, respectively.
With a team of experienced executives, investors, and entrepreneurs who have spent over 20 years within their target sectors, SemperVirens has built a reputation for more than just providing capital — it actively helps portfolio companies secure strategic partnerships, accelerate enterprise adoption, and drive to achieve scale in ways that set it apart from traditional VC firms.
This approach helped many of its portfolio companies accelerate their go-to-market pathway, dating back to the firm’s earliest investments in unicorns like Multiverse, Remote, Rightway Healthcare, and Spring Health.
As an early firm to embrace novel applications of AI for transforming complex industries, SemperVirens is strategically positioned to elevate high-growth startups driving meaningful advancements in healthcare, fintech, and the enterprise. And some of the firm’s most recent investments in these areas include Midi Health, Nayya, Stepful, Sully AI, and Thatch.
Through the new funds, SemperVirens will continue backing companies that build category-defining solutions that increase access and improve outcomes.
For these new funds, SemperVirens welcomed an impressive mix of institutional, impact-oriented, and strategic LPs, including Paychex, ADP Ventures, Healthworx, The Cigna Group Ventures, Guardian, MetLife, Unum, Strada Education Foundation, Impact Engine, and more.
Since its founding in 2018, the firm has leveraged its network of Fortune 500 employers, HR/people executives, brokers, insurers, hospital systems, financial institutions and other strategic partners to support its portfolio companies. And this has resulted in expansive access to enterprise buyers and accelerated go-to-market strategies, ultimately facilitating over $500 million in revenue opportunities with $100 million already closed.
Along with its network, SemperVirens also operates a robust Executive Advisory Board dedicated to bridging the gap between the country’s most ambitious technology entrepreneurs and the leaders with the influence to implement these innovative solutions in the real world. The firm’s Advisor Groups now include more than 190 senior-level executives, including leaders from eight of the ten largest employers in the US and former healthcare executives at major healthcare and insurance plans.
KEY QUOTES:
“Going back to the earliest days of SemperVirens, we always have been motivated by a fundamental belief that the best VCs act like operators and need to earn a spot on the cap table. Our new set of funds positions us to double down on this approach, which clearly resonates with our founders, LPs and partners.”
– Robby Peters, SemperVirens co-founder and Managing Partner
“Venture capital has evolved. There has been a bifurcation, resulting in large, multi-stage funds that invest broadly – their strategy is essentially their size – and smaller, specialized funds with concrete operational value add. SemperVirens is unique in the sense that we deliver the value and specialization of the best boutique firms with the resources and amplification potential of the larger firms.”
– Allison Baum Gates, General Partner at SemperVirens
“We deeply value SemperVirens’ expertise in the future of work, their ability to rigorously vet companies through their platform, and their proven track record of identifying and scaling high-impact ventures.”
– Usman (Oz) Khan, SVP at ADP Ventures
“SemperVirens has been an incredible partner to us from day one. The team immediately jumped in and made dozens of introductions to healthcare executives, impactful customers, and advisors. They also supported key distribution partnerships that are changing the trajectory of our business. More than introductions, the team has been a valuable thought partner, helping us navigate and accelerate distribution across diverse customer segments and channel partnerships.”
– Chris Ellis, co-founder and CEO of Thatch, a SemperVirens and a16z backed portfolio company
“I’ve worked at the intersection of healthcare and financial sustainability for more than three decades, and one thing remains constant: the need for solutions that are both innovative and practical. SemperVirens brings together people who understand that balance—investors, operators, and entrepreneurs who are deeply engaged in solving real challenges. Being part of the SemperVirens ecosystem means having the chance to shape ideas before they hit the market, ensuring they truly serve employers, health plans, and the people who rely on them.”
– SemperVirens Advisor Molly Loftus, former CEO & President at Consortium Health Plans
